Business Context and Reporting Period
This Form 8-K is a current report filed by Pieris Pharmaceuticals, Inc. (not Palvela Therapeutics, Inc., as indicated in the metadata) on June 8, 2020. The registrant is a Nevada corporation with its principal executive offices in Boston, MA, and its common stock trades on The Nasdaq Capital Market under the symbol PIRS.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is an event notification and does not contain financial statements or performance metrics.
Material Changes
There are no material financial changes reported in this filing. The sole material event is the change in the format of the company's 2020 annual meeting of stockholders.
Guidance, Outlook, and Management Commentary
Event Details: Due to the public health impact of the coronavirus pandemic, the 2020 annual meeting of stockholders, originally scheduled for Tuesday, June 23, 2020, at 8:00 a.m. Eastern Time, will be conducted in a virtual format rather than in-person.
Reference: A press release detailing this change is attached as Exhibit 99.1 and incorporated by reference.
Key Facts for Investor Verification
- Verify the specific virtual meeting platform and login instructions in the attached press release (Exhibit 99.1).
- Confirm the date and time of the virtual annual meeting remains June 23, 2020, at 8:00 a.m. Eastern Time.
- Note that this filing contains no financial data; refer to the most recent 10-Q or 10-K for financial performance.